VCYT VERACYTE, INC.
Nasdaq · SEC CIK 1384101 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $22.25M 37 sales by 11 insiders
- Filings on record
- 275 since 2021-07-20, latest 2026-09-22 17:16
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Stapley Marc | CEO, Dir | — | $8.92M |
| JONES EVAN/ FA | Dir | — | $2.00M |
| Chambers Rebecca | CFO | — | $1.91M |
| McGuire Annie | SVP, GC | — | $1.80M |
| Wygant Jonathan | VP, CAO | — | $1.54M |
| EASTHAM KARIN | Dir | — | $1.49M |
| Febbo Phillip G. | Chief Scientific, Med Off | — | $1.35M |
| Leite John | Gbl Chief Commercial Off | — | $1.34M |
| EPSTEIN ROBERT S | Dir | — | $1.19M |
| Holstein Jens | Dir | — | $628.3K |
Transactions 342
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-23 | 2025-06-18 | VCYT | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +9,321 | 73.9K | +14% | $0 | |
| 2025-06-23 | 2025-06-18 | VCYT | Barr Eliav | Dir | A - Grant | $0.00 | +9,321 | 51.2K | +22% | $0 | |
| 2025-06-23 | 2025-06-18 | VCYT | JONES EVAN/ FA | Dir | A - Grant | $0.00 | +9,321 | 43.7K | +27% | $0 | |
| 2025-06-23 | 2025-06-18 | VCYT | Holstein Jens | Dir | A - Grant | $0.00 | +9,321 | 37.2K | +33% | $0 | |
| 2025-06-23 | 2025-06-18 | VCYT | Miller Thomas F. | Dir | A - Grant | $0.00 | +9,321 | 25.8K | +56% | $0 | |
| 2025-06-23 | 2025-06-18 | VCYT | EASTHAM KARIN | Dir | A - Grant | $0.00 | +9,321 | 23.2K | +67% | $0 | |
| 2025-06-23 | 2025-06-18 | VCYT | Bhanji Muna | Dir | A - Grant | $0.00 | +9,321 | 39.3K | +31% | $0 | |
| 2025-06-23 | 2025-06-18 | VCYT | Shafer David Brent | Dir | A - Grant | $0.00 | +9,321 | 25.8K | +56% | $0 | |
| 2025-06-17 | 2025-06-13 | VCYT | Bhanji Muna | Dir | S - Sale | $26.67 | -4,589 | 30.0K | -13% | -$122.4K | |
| 2025-06-17 | 2025-06-13 | VCYT | EASTHAM KARIN | Dir | S - Sale | $26.66 | -4,590 | 13.9K | -25% | -$122.4K | |
| 2025-06-06 | 2025-06-04 | VCYT | Leite John | Chief Commercial Off.-CLIA | S - Sale | $27.20 | -2,809 | 94.5K | -3% | -$76.4K | |
| 2025-06-04 | 2025-06-02 | VCYT | McGuire Annie | SVP, GC | F - Tax | $26.74 | -3,505 | 97.0K | -3% | -$93.7K | |
| 2025-06-04 | 2025-06-02 | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $26.74 | -2,955 | 103.7K | -3% | -$79.0K | |
| 2025-06-04 | 2025-06-02 | VCYT | Chambers Rebecca | CFO | F - Tax | $26.74 | -5,370 | 138.5K | -4% | -$143.6K | |
| 2025-06-04 | 2025-06-02 | VCYT | Leite John | Chief Commercial Off.-CLIA | F - Tax | $26.74 | -2,900 | 97.3K | -3% | -$77.5K | |
| 2025-06-04 | 2025-06-02 | VCYT | Wygant Jonathan | VP, CAO | F - Tax | $26.74 | -1,848 | 47.9K | -4% | -$49.4K | |
| 2025-06-04 | 2025-06-02 | VCYT | Stapley Marc | CEO, Dir | F - Tax | $26.74 | -9,399 | 349.2K | -3% | -$251.3K | |
| 2025-03-10 | 2025-03-06 | VCYT | Chambers Rebecca | CFO | A - Grant | $0.00 | +30.2K | 143.9K | +27% | $0 | |
| 2025-03-10 | 2025-03-06 | VCYT | Wygant Jonathan | VP, CAO | A - Grant | $0.00 | +13.3K | 49.8K | +36% | $0 | |
| 2025-03-10 | 2025-03-06 | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | A - Grant | $0.00 | +24.2K | 106.7K | +29% | $0 | |
| 2025-03-10 | 2025-03-06 | VCYT | McGuire Annie | SVP, GC | A - Grant | $0.00 | +30.2K | 100.5K | +43% | $0 | |
| M | 2025-03-10 | 2025-03-07 | VCYT | Leite John | Chief Commercial Off.-CLIA | S - Sale | $31.66 | -7,411 | 100.2K | -7% | -$234.6K |
| 2025-03-10 | 2025-03-06 | VCYT | Leite John | Chief Commercial Off.-CLIA | A - Grant | $0.00 | +36.2K | 107.7K | +51% | $0 | |
| 2025-03-10 | 2025-03-06 | VCYT | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +90.6K | 358.6K | +34% | $0 | |
| M | 2025-03-06 | 2025-03-04 | VCYT | Stapley Marc | CEO, Dir | S - Sale | $33.34 | -52.7K | 292.5K | -15% | -$1.76M |
| 2025-03-06 | 2025-03-04 | VCYT | McGuire Annie | SVP, GC | S - Sale | $33.69 | -1,142 | 70.3K | -2% | -$38.5K | |
| M | 2025-03-06 | 2025-03-04 | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | S - Sale | $33.34 | -8,037 | 82.5K | -9% | -$268.0K |
| 2025-03-03 | 2025-03-02 | VCYT | Wygant Jonathan | VP, CAO | F - Tax | $34.76 | -4,301 | 36.5K | -11% | -$149.5K | |
| M | 2025-03-03 | 2025-02-27+ | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $34.12 | -22.4K | 97.3K | -19% | -$765.1K |
| 2025-03-03 | 2025-02-27 | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | A - Grant | $0.00 | +30.6K | 113.0K | +37% | $0 | |
| M | 2025-03-03 | 2025-02-27+ | VCYT | Stapley Marc | CEO, Dir | F - Tax | $34.18 | -54.6K | 341.1K | -14% | -$1.87M |
| 2025-03-03 | 2025-02-27 | VCYT | Stapley Marc | CEO, Dir | A - Grant | $0.00 | +67.3K | 375.3K | +22% | $0 | |
| 2025-03-03 | 2025-02-27 | VCYT | Leite John | Chief Commercial Off.-CLIA | S - Sale | $33.84 | -5,746 | 79.1K | -7% | -$194.4K | |
| 2025-03-03 | 2025-02-27 | VCYT | Leite John | Chief Commercial Off.-CLIA | A - Grant | $0.00 | +11.0K | 84.8K | +15% | $0 | |
| 2025-03-03 | 2025-03-02 | VCYT | Leite John | Chief Commercial Off.-CLIA | F - Tax | $34.76 | -7,650 | 71.4K | -10% | -$265.9K | |
| M | 2025-03-03 | 2025-02-27+ | VCYT | Chambers Rebecca | CFO | F - Tax | $34.28 | -23.0K | 124.8K | -16% | -$787.9K |
| 2025-03-03 | 2025-02-27 | VCYT | Chambers Rebecca | CFO | A - Grant | $0.00 | +23.2K | 136.7K | +20% | $0 | |
| M | 2025-03-03 | 2025-02-27+ | VCYT | McGuire Annie | SVP, GC | F - Tax | $34.34 | -15.3K | 79.7K | -16% | -$523.8K |
| 2025-03-03 | 2025-02-27 | VCYT | McGuire Annie | SVP, GC | A - Grant | $0.00 | +13.5K | 86.7K | +18% | $0 | |
| 2025-02-05 | 2025-02-03 | VCYT | Chambers Rebecca | CFO | S - Sale | $43.85 | -527 | 113.5K | -0.5% | -$23.1K | |
| D | 2025-01-08 | 2025-01-06 | VCYT | EPSTEIN ROBERT S | Dir | M - OptEx | $8.04 | +20.0K | 64.6K | +45% | +$160.8K |
| DM | 2025-01-06 | 2025-01-02 | VCYT | EASTHAM KARIN | Dir | S - Sale+OE | $40.30 | -10.0K | 23.2K | -30% | -$403.0K |
| D | 2025-01-06 | 2025-01-02 | VCYT | EASTHAM KARIN | Dir | M - OptEx | $5.28 | +10.0K | 28.5K | +54% | +$52.8K |
| M | 2024-12-17 | 2024-12-13 | VCYT | Stapley Marc | CEO, Dir | S - Sale | $43.43 | -5,590 | 307.3K | -2% | -$242.7K |
| 2024-12-06 | 2024-12-04 | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | S - Sale | $44.09 | -3,934 | 82.4K | -5% | -$173.5K | |
| 2024-12-06 | 2024-12-04 | VCYT | McGuire Annie | SVP, GC | S - Sale | $44.02 | -18.7K | 72.9K | -20% | -$823.1K | |
| 2024-12-04 | 2024-12-02 | VCYT | Wygant Jonathan | VP, CAO | F - Tax | $44.12 | -1,087 | 41.2K | -3% | -$48.0K | |
| 2024-12-04 | 2024-12-03 | VCYT | Wygant Jonathan | VP, CAO | S - Sale | $43.36 | -956 | 40.3K | -2% | -$41.5K | |
| 2024-12-04 | 2024-12-02 | VCYT | Stapley Marc | CEO, Dir | F - Tax | $44.12 | -5,748 | 312.9K | -2% | -$253.6K | |
| 2024-12-04 | 2024-12-02 | VCYT | Leite John | Chief Commercial Off.-CLIA | F - Tax | $44.12 | -1,314 | 74.9K | -2% | -$58.0K | |
| 2024-12-04 | 2024-12-03 | VCYT | Leite John | Chief Commercial Off.-CLIA | S - Sale | $43.25 | -1,050 | 73.8K | -1% | -$45.4K | |
| 2024-12-04 | 2024-12-02 | VCYT | Chambers Rebecca | CFO | F - Tax | $44.12 | -3,464 | 121.0K | -3% | -$152.8K | |
| 2024-12-04 | 2024-12-03 | VCYT | Chambers Rebecca | CFO | S - Sale | $43.23 | -7,000 | 114.0K | -6% | -$302.6K | |
| 2024-12-04 | 2024-12-02 | VCYT | Febbo Phillip G. | Chief Scientific, Med Off | F - Tax | $44.12 | -6,738 | 86.3K | -7% | -$297.3K | |
| 2024-12-04 | 2024-12-02 | VCYT | McGuire Annie | SVP, GC | F - Tax | $44.12 | -1,918 | 91.6K | -2% | -$84.6K | |
| 2024-11-29 | 2024-11-27 | VCYT | Wygant Jonathan | VP, CAO | S - Sale | $42.89 | -5,032 | 42.3K | -11% | -$215.8K | |
| M | 2024-11-21 | 2024-11-19 | VCYT | EASTHAM KARIN | Dir | S - Sale | $38.34 | -14.7K | 18.5K | -44% | -$564.8K |
| D | 2024-11-14 | 2024-11-12 | VCYT | EPSTEIN ROBERT S | Dir | S - Sale+OE | $38.32 | -15.0K | 44.6K | -25% | -$574.8K |
| D | 2024-11-14 | 2024-11-12 | VCYT | EPSTEIN ROBERT S | Dir | M - OptEx | $8.04 | +15.0K | 59.6K | +34% | +$120.6K |
| 2024-11-14 | 2024-11-12 | VCYT | Chambers Rebecca | CFO | S - Sale | $38.34 | -15.3K | 124.5K | -11% | -$585.6K | |
| I | 2024-09-23 | 2024-09-19 | VCYT | JONES EVAN/ FA | Dir | S - Sale | $35.23 | -5,173 | 0 | -100% | -$182.2K |
| 2024-09-06 | 2024-09-04 | VCYT | Leite John | Chief Commercial Off.-CLIA | S - Sale | $29.78 | -5,479 | 76.2K | -7% | -$163.2K | |
| 2024-09-04 | 2024-09-02 | VCYT | Wygant Jonathan | VP, CAO | F - Tax | $31.55 | -1,087 | 47.3K | -2% | -$34.3K | |
| 2024-09-04 | 2024-09-02 | VCYT | Leite John | Chief Commercial Off.-CLIA | F - Tax | $31.55 | -1,315 | 81.7K | -2% | -$41.5K | |
| 2024-09-04 | 2024-09-02 | VCYT | Stapley Marc | CEO, Dir | F - Tax | $31.55 | -5,748 | 318.7K | -2% | -$181.3K | |
| 2024-09-04 | 2024-09-02 | VCYT | Chambers Rebecca | CFO | F - Tax | $31.55 | -3,464 | 139.8K | -2% | -$109.3K | |
| 2024-09-04 | 2024-09-02 | VCYT | McGuire Annie | SVP, GC | F - Tax | $31.55 | -1,920 | 93.5K | -2% | -$60.6K | |
| 2024-09-04 | 2024-09-03 | VCYT | Miller Thomas F. | Dir | A - Grant | $0.00 | +16.5K | 16.5K | New | $0 | |
| 2024-09-04 | 2024-09-03 | VCYT | Shafer David Brent | Dir | A - Grant | $0.00 | +16.5K | 16.5K | New | $0 | |
| DM | 2024-08-14 | 2024-08-12+ | VCYT | JONES EVAN/ FA | Dir | S - Sale+OE | $32.20 | -20.6K | 46.3K | -31% | -$661.8K |
| DMI | 2024-08-14 | 2024-08-12+ | VCYT | JONES EVAN/ FA | Dir | S - Sale+OE | $32.20 | -27.3K | 32.4K | -46% | -$878.7K |
| D | 2024-08-14 | 2024-08-13 | VCYT | JONES EVAN/ FA | Dir | M - OptEx | $10.41 | +8,486 | 54.8K | +18% | +$88.3K |
| DI | 2024-08-13 | 2024-08-09 | VCYT | JONES EVAN/ FA | Dir | S - Sale+OE | $30.03 | -746 | 32.5K | -2% | -$22.4K |
| D | 2024-08-13 | 2024-08-09 | VCYT | JONES EVAN/ FA | Dir | M - OptEx | $10.41 | +300 | 47.4K | +0.6% | +$3,123 |
| D | 2024-08-13 | 2024-08-09 | VCYT | JONES EVAN/ FA | Dir | S - Sale+OE | $30.03 | -1,032 | 46.4K | -2% | -$31.0K |
| AI | 2024-08-13 | 2024-08-07 | VCYT | JONES EVAN/ FA | Dir | S - Sale | $30.32 | -1,965 | 33.2K | -6% | -$59.6K |
| A | 2024-08-13 | 2024-08-07 | VCYT | JONES EVAN/ FA | Dir | S - Sale | $30.32 | -3,143 | 47.1K | -6% | -$95.3K |
| M | 2024-08-09 | 2024-08-07 | VCYT | Holstein Jens | Dir | S - Sale | $29.00 | -5,000 | 27.9K | -15% | -$145.0K |
| D | 2024-08-09 | 2024-08-07 | VCYT | JONES EVAN/ FA | Dir | M - OptEx | $10.41 | +1,214 | 50.3K | +2% | +$12.6K |
| D | 2024-08-09 | 2024-08-07 | VCYT | JONES EVAN/ FA | Dir | S - Sale+OE | $30.32 | -5,108 | 45.2K | -10% | -$154.9K |
| M | 2024-07-18 | 2024-07-16 | VCYT | Holstein Jens | Dir | S - Sale | $24.50 | -5,000 | 32.9K | -13% | -$122.5K |
| 2024-07-18 | 2024-07-16 | VCYT | EASTHAM KARIN | Dir | S - Sale | $25.00 | -7,500 | 33.2K | -18% | -$187.5K | |
| 2024-07-18 | 2024-07-16 | VCYT | Leite John | Chief Commercial Off.-CLIA | S - Sale | $25.00 | -1,277 | 83.0K | -2% | -$31.9K | |
| 2024-06-17 | 2024-06-13 | VCYT | Barr Eliav | Dir | A - Grant | $0.00 | +11.5K | 41.9K | +38% | $0 | |
| 2024-06-17 | 2024-06-13 | VCYT | Bhanji Muna | Dir | A - Grant | $0.00 | +11.5K | 34.6K | +50% | $0 | |
| 2024-06-17 | 2024-06-13 | VCYT | Holstein Jens | Dir | A - Grant | $0.00 | +11.5K | 37.9K | +43% | $0 | |
| 2024-06-17 | 2024-06-13 | VCYT | EASTHAM KARIN | Dir | A - Grant | $0.00 | +11.5K | 40.7K | +39% | $0 | |
| 2024-06-17 | 2024-06-13 | VCYT | JONES EVAN/ FA | Dir | A - Grant | $0.00 | +11.5K | 49.1K | +31% | $0 | |
| 2024-06-17 | 2024-06-13 | VCYT | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +11.5K | 44.6K | +35% | $0 | |
| 2024-06-13 | 2024-06-11 | VCYT | EASTHAM KARIN | Dir | S - Sale | $20.59 | -3,870 | 29.3K | -12% | -$79.7K | |
| 2024-06-11 | 2024-06-10 | VCYT | Bhanji Muna | Dir | S - Sale | $20.32 | -3,870 | 23.1K | -14% | -$78.6K | |
| D | 2024-06-11 | 2024-06-07 | VCYT | EASTHAM KARIN | Dir | M - OptEx | $10.41 | +2,500 | 35.6K | +8% | +$26.0K |
| D | 2024-06-11 | 2024-06-07 | VCYT | EASTHAM KARIN | Dir | S - Sale+OE | $20.97 | -2,500 | 33.1K | -7% | -$52.4K |
| 2024-06-04 | 2024-06-02 | VCYT | Stapley Marc | CEO, Dir | F - Tax | $20.75 | -5,746 | 324.0K | -2% | -$119.2K | |
| 2024-06-04 | 2024-06-02 | VCYT | Leite John | Chief Commercial Off.-CLIA | F - Tax | $20.75 | -1,314 | 84.2K | -2% | -$27.3K | |
| 2024-06-04 | 2024-06-02 | VCYT | Chambers Rebecca | CFO | F - Tax | $20.75 | -3,462 | 143.2K | -2% | -$71.8K | |
| 2024-06-04 | 2024-06-02 | VCYT | Wygant Jonathan | VP, CAO | F - Tax | $20.75 | -1,087 | 48.0K | -2% | -$22.6K | |
| 2024-06-04 | 2024-06-02 | VCYT | McGuire Annie | SVP, GC | F - Tax | $20.75 | -1,919 | 95.4K | -2% | -$39.8K | |
| 2024-05-30 | 2024-05-28 | VCYT | Bhanji Muna | Dir | S - Sale | $21.00 | -1,539 | 27.0K | -5% | -$32.3K | |
| D | 2024-04-02 | 2024-04-01 | VCYT | EASTHAM KARIN | Dir | S - Sale+OE | $21.65 | -10.0K | 33.1K | -23% | -$216.5K |
Purchase Sale Sale after option exercise All abbreviations